You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
Latest Insulin Articles
Popular Insulin Articles
Highly Recommended Insulin Articles
Send a link to this page to your friends and colleagues.
The National Institutes of Health will fund studies at 11 research centers in the United States, Canada, Sweden and Norway to look into ways to improve outcomes and lessen the side effects from islet cell transplantations in people with type 1 diabetes.
A transplantation takes islets from donor pancreases and infuses them into the liver of a type 1 patient. If the islets successfully lodge in the liver’s small blood vessels, they begin producing insulin—an astounding result given that the autoimmune aspects of type 1 almost invariably destroy the body’s insulin-making capabilities.
However, islet recipients must take drugs that suppress the immune system and keep it from rejecting the transplants. Researchers will use NIH funding to find more effective combinations of anti-rejection drugs that will reduce toxic side effects and increase the likelihood of the islets “taking.”
Another goal is to find ways to generate a much greater supply of islets so that more type 1s can benefit from transplantations.
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.